Citation Impact
Citing Papers
Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate
2019 StandoutScienceNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
2017
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
In vivo quantitative imaging of tumor pH by nanosonophore assisted multispectral photoacoustic imaging
2017
Engineering precision nanoparticles for drug delivery
2020 Standout
Targeting natural killer cells and natural killer T cells in cancer
2012
Oncology Meets Immunology: The Cancer-Immunity Cycle
2013 Standout
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Modular and tunable biological feedback control using a de novo protein switch
2019 StandoutNatureNobel
Combining immunotherapy and targeted therapies in cancer treatment
2012
Chronic inflammation in the etiology of disease across the life span
2019 Standout
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate
2016 Nature
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
The spectrum of T cell metabolism in health and disease
2017
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
The Principles of Engineering Immune Cells to Treat Cancer
2017
Interactions in the (Pre)metastatic Niche Support Metastasis Formation
2019
Immuno-Oncology: Emerging Targets and Combination Therapies
2018
Engineering Natural Killer Cells for Cancer Immunotherapy
2017
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Comparing the effects of different cell death programs in tumor progression and immunotherapy
2018
Ophidian envenomation strategies and the role of purines
2002
Delivery technologies for cancer immunotherapy
2019 Standout
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor
2017
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
Sodium in the microenvironment regulates immune responses and tissue homeostasis
2019
T cell exhaustion during persistent viral infections
2015
8thAnnual European Antibody Congress 2012
2013
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Molecular mechanisms of T cell co-stimulation and co-inhibition
2013 Standout
Emerging Biological Principles of Metastasis
2017 Standout
M-Type Phospholipase A 2 Receptor as Target Antigen in Idiopathic Membranous Nephropathy
2009 Standout
Control of Metastasis by NK Cells
2017
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
The blockade of immune checkpoints in cancer immunotherapy
2012 Standout
Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
2021
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Strategies and challenges for the next generation of antibody–drug conjugates
2017 Standout
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
Transcription factor Ikzf1 associates with Foxp3 to repress gene expression in Treg cells and limit autoimmunity and anti-tumor immunity
2024 StandoutNobel
Mitochondria as multifaceted regulators of cell death
2019 Standout
PGE2-EP2/EP4 signaling elicits immunosuppression by driving the mregDC-Treg axis in inflammatory tumor microenvironment
2022 StandoutNobel
Mitochondrial TCA cycle metabolites control physiology and disease
2020 Standout
Defining trained immunity and its role in health and disease
2020 Standout
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Novel tools to assist neoepitope targeting in personalized cancer immunotherapy
2017
α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming
2017
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
2018 Standout
Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor
2005
TIMER2.0 for analysis of tumor-infiltrating immune cells
2020 Standout
Oxygen-Self-Produced Nanoplatform for Relieving Hypoxia and Breaking Resistance to Sonodynamic Treatment of Pancreatic Cancer
2017
First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings
2021
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
The TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness
2016
Killer Immunoglobulin-like Receptors and Tumor Immunity
2014
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges
2019
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
CAR T cell immunotherapy for human cancer
2018 StandoutScience
Regulatory T cells expressing abundant CTLA‐4 on the cell surface with a proliferative gene profile are key features of human head and neck cancer
2018 StandoutNobel
Works of David Clever being referenced
Cish actively silences TCR signaling in CD8+ T cells to maintain tumor tolerance
2015
Ionic immune suppression within the tumour microenvironment limits T cell effector function
2016 Nature
Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche
2016
Inhibition of AKT signaling uncouples T cell differentiation from expansion for receptor-engineered adoptive immunotherapy
2017
Swine as a model of skin inflammation
1993
Reprogramming antitumor immunity
2014
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
2011